Ritchie DS - Search Results

1

The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.

Cheah CY, Hofman MS, Seymour JF, Ritchie DS, Dickinson M, Wirth A, Prince HM, Wolf M, Januszcewicz EH, Carney DA, Herbert KE, Harrison SJ, Burbury KL, Tam CS. Cheah CY, et al. Among authors: ritchie ds. Leuk Lymphoma. 2015 Jan;56(1):49-56. doi: 10.3109/10428194.2014.910656. Epub 2014 Jun 16. Leuk Lymphoma. 2015. PMID: 24724780

2

Acute left ventricular failure following melphalan and fludarabine conditioning.

Ritchie DS, Seymour JF, Roberts AW, Szer J, Grigg AP. Ritchie DS, et al. Bone Marrow Transplant. 2001 Jul;28(1):101-3. doi: 10.1038/sj.bmt.1703098. Bone Marrow Transplant. 2001. PMID: 11498753

3

Successful transplant outcome in a morbidly obese patient with acute myeloblastic leukemia.

Ritchie DS, Wirth A, Grigg AP. Ritchie DS, et al. Leuk Lymphoma. 2001 Sep-Oct;42(5):1111-4. doi: 10.3109/10428190109097732. Leuk Lymphoma. 2001. PMID: 11697629

4

Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.

Tam C, Seymour JF, Brown M, Campbell P, Scarlett J, Underhill C, Ritchie D, Bond R, Grigg AP. Tam C, et al. Haematologica. 2005 May;90(5):700-2. Haematologica. 2005. PMID: 15921393

5

In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.

Ritchie D, Mileshkin L, Wall D, Bartholeyns J, Thompson M, Coverdale J, Lau E, Wong J, Eu P, Hicks RJ, Prince HM. Ritchie D, et al. Cancer Immunol Immunother. 2007 Feb;56(2):155-63. doi: 10.1007/s00262-006-0181-3. Epub 2006 May 30. Cancer Immunol Immunother. 2007. PMID: 16733671 Free PMC article. Clinical Trial.

6

The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.

Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S, Szer J, Prince HM. Ritchie DS, et al. Ann Hematol. 2007 Feb;86(2):101-5. doi: 10.1007/s00277-006-0193-2. Epub 2006 Nov 7. Ann Hematol. 2007. PMID: 17089127 Clinical Trial.

7

The role of second autografts in the treatment of Hodgkin lymphoma.

Ritchie DS. Ritchie DS. Leuk Lymphoma. 2007 May;48(5):847-8. doi: 10.1080/10428190701361232. Leuk Lymphoma. 2007. PMID: 17487723 No abstract available.

8

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.

Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, Beshay V, Ritchie D, Simmons P, Milner AD, Zeldis JB, Prince HM. Mileshkin L, et al. Haematologica. 2007 Aug;92(8):1075-82. doi: 10.3324/haematol.11208. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640854 Free article.

9

The Late Effects Clinic in action: for survivors of childhood malignancy.

Campbell BA, Wheeler G, Seymour JF, Ritchie D, Goroncy N. Campbell BA, et al. Acta Oncol. 2007;46(8):1152-8. doi: 10.1080/02841860701426815. Acta Oncol. 2007. PMID: 17851871

10

Plasma cell lysate as an antigen source in multiple myeloma immunotherapy.

Ritchie DS. Ritchie DS. Leuk Lymphoma. 2007 Oct;48(10):1894-5. doi: 10.1080/10428190701625107. Leuk Lymphoma. 2007. PMID: 17917956 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters